Stephen S. Gottlieb

Stephen S. Gottlieb's AcademicInfluence.com Rankings

Stephen S. Gottlieb

Physics

#7588

World Rank

#9630

Historical Rank

physics Degrees

Download Badge

Physics

Stephen S. Gottlieb's Degrees

PhD Physics Stanford University
Masters Physics Stanford University
Bachelors Physics Stanford University

Why Is Stephen S. Gottlieb Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephen S. Gottlieb's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) (1999) (4830)
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) (1999) (4830)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. (2000) (1183)
HIV infection and the risk of acute myocardial infarction. (2013) (1099)
Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. (1998) (982)
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. (2004) (888)
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. (1992) (671)
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) (2000) (595)
Ventricular dysfunction and the risk of stroke after myocardial infarction. (1997) (579)
The prognostic importance of different definitions of worsening renal function in congestive heart failure. (2002) (556)
Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure (1996) (555)
Effect of nesiritide in patients with acute decompensated heart failure. (2011) (516)
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. (2004) (491)
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). (2016) (491)
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure (2000) (476)
The influence of age, gender, and race on the prevalence of depression in heart failure patients. (2004) (471)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy (2002) (384)
Prevention and reversal of nitrate tolerance in patients with congestive heart failure. (1987) (370)
Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. (1989) (362)
Hemodynamic and Neurohormonal Effects of the Angiotensin II Antagonist Losartan in Patients With Congestive Heart Failure (1993) (298)
Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. (1995) (277)
Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. (2012) (272)
Cardiorenal Syndrome: New Perspectives (2010) (264)
Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. (2006) (234)
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. (2005) (230)
Elevated Concentrations of Endogenous Ouabain in Patients With Congestive Heart Failure (1992) (219)
Metoprolol CR/XL in Female Patients With Heart Failure: Analysis of the Experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF) (2002) (216)
Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. (1987) (215)
A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. (2002) (204)
Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. (1994) (200)
Increased Resting Metabolic Rate in Patients with Congestive Heart Failure (1994) (199)
Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. (2011) (199)
Nesiritide Does Not Improve Renal Function in Patients With Chronic Heart Failure and Worsening Serum Creatinine (2004) (196)
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study (2017) (184)
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. (1996) (172)
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. (2000) (171)
Dead is dead—artificial definitions are no substitute (1997) (170)
Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. (2000) (170)
The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure (2000) (166)
B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. (2006) (157)
Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. (2000) (145)
Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia. (2006) (144)
Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality (2006) (142)
HIV Infection and Cardiovascular Disease in Women (2014) (127)
Effects of exercise training on peak performance and quality of life in congestive heart failure patients. (1999) (126)
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) Trial (2007) (126)
The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. (2005) (124)
Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). (2009) (121)
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. (2008) (120)
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). (2005) (119)
Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. (1990) (118)
Daily energy expenditure in free-living heart failure patients. (1997) (117)
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. (2001) (114)
Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. (1995) (105)
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. (2007) (104)
Quality of life and psychological status of patients with implantable cardioverter defibrillators. (2006) (99)
Tolerability of &bgr;-Blocker Initiation and Titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) (2002) (97)
Quality of life and psychological status of patients with implantable cardioverter defibrillators (2006) (95)
Efficacy, safety and tolerability of β-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure (2004) (90)
Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure. (1987) (90)
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial. (1995) (86)
Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure. (1987) (85)
Depression in heart failure: biobehavioral mechanisms. (2011) (84)
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). (2013) (81)
Importance and management of chronic sleep apnoea in cardiology. (2013) (79)
Plasma leptin concentrations and energy expenditure in heart failure patients. (1997) (77)
The effect of a randomized trial of home telemonitoring on medical costs, 30-day readmissions, mortality, and health-related quality of life in a cohort of community-dwelling heart failure patients. (2014) (75)
Cardiac Calcitropes, Myotropes, and Mitotropes: JACC Review Topic of the Week. (2019) (74)
New York Heart Association functional class predicts exercise parameters in the current era. (2009) (73)
Skeletal muscle atrophy and peak oxygen consumption in heart failure. (1997) (72)
Energy expenditure and symptom severity in men with heart failure. (1996) (71)
Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure. (2009) (70)
The acute hemodynamic effects of right ventricular septal pacing in patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1997) (68)
Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure. (1990) (64)
Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia. (1986) (63)
The erythrocyte sedimentation rate in congestive heart failure. (1991) (62)
Sarcopenia in aging humans: the impact of menopause and disease. (1995) (60)
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure (2017) (58)
Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. (2011) (56)
Importance of magnesium in congestive heart failure. (1989) (55)
Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with heart failure. (1994) (54)
Rationale, design, and organization of the metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF) (1997) (54)
Depression and Human Immunodeficiency Virus Infection Are Risk Factors for Incident Heart Failure Among Veterans: Veterans Aging Cohort Study (2015) (54)
Combinatorial Pharmacogenetic Interactions of Bucindolol and β1, α2C Adrenergic Receptor Polymorphisms (2012) (53)
Impedance cardiography: More questions than answers (2006) (50)
Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure. (1993) (49)
Preoperative Endogenous Ouabain Predicts Acute Kidney Injury in Cardiac Surgery Patients* (2013) (49)
Diuretics: Still the mainstay of treatment (2008) (49)
Benefits and risks of anticoagulation resumption following traumatic brain injury. (2014) (49)
Metoprolol CR/XL in patients with heart failure: A pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction. (1999) (46)
Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. (1986) (46)
High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure. (1994) (44)
A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction (2017) (43)
Exploration of patients' readiness for an eHealth management program for chronic heart failure: a preliminary study. (2008) (42)
Daily energy requirements in heart failure patients. (1997) (42)
Cardiac resynchronization therapy for heart failure. (2002) (42)
Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure. (2004) (40)
The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. (2006) (40)
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. (2015) (38)
Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure: Results From the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) (2014) (38)
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation (2013) (38)
Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. (2009) (37)
Renal Hemodynamic Effects of Serelaxin in Patients With Chronic Heart Failure: A Randomized, Placebo-Controlled Study (2014) (36)
Hypertrophy‐Associated Polymorphisms Ascertained in a Founder Cohort Applied to Heart Failure Risk and Mortality (2011) (35)
Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study (2017) (34)
Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study (2010) (34)
Renal response to indomethacin in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. (1992) (33)
The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure. (1998) (33)
Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction. (2001) (33)
Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure. (1989) (31)
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure. (1987) (30)
Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure. (2020) (29)
Prognostic significance of active and modified forms of endothelin 1 in patients with heart failure with reduced ejection fraction. (2014) (29)
The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study. (2010) (29)
Effect of Beta-Blockade on Mortality Among High-Risk and Low-Risk Patients After Myocardial Infarction (1999) (29)
Prolongation of QT interval and antiarrhythmic action of bepridil. (1985) (29)
Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure). (2003) (28)
Effect of metoprolol on absolute myocardial blood flow in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. (2002) (28)
Sex, digitalis, and the sodium pump. (2003) (28)
Protein-energy malnutrition in patients with ischemic and nonischemicdilated cardiomyopathy and congestive heart failure☆ (1994) (27)
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]). (2010) (27)
Association between depressive symptoms and fibrosis markers: The Cardiovascular Health Study (2010) (27)
Trastuzumab-induced cardiomyopathy: incidence and associated risk factors in an inner-city population. (2014) (26)
Effect of chronic changes in heart rate on congestive heart failure. (2007) (26)
Renal Effects of Adenosine A1-Receptor Antagonists in Congestive Heart Failure (2012) (25)
Perioperative beta-blockade: a survey of physician attitudes in the department of Veterans Affairs. (2004) (24)
A Genome-Wide Association Study of Idiopathic Dilated Cardiomyopathy in African Americans (2018) (24)
Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure. (1990) (24)
The Effect of Nitroprusside on Pulmonary Edema, Oxygen Exchange, and Blood Flow in Hydrochloric Acid Aspiration (1987) (24)
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial. (2005) (23)
Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. (2008) (22)
Adenosine A1 antagonists and the cardiorenal syndrome (2008) (22)
The effect of dementia on medication use and adherence among Medicare beneficiaries with chronic heart failure. (2012) (20)
Exploration of Patients' Readiness for an eHealth Management Program for Chronic Heart Failure: A Preliminary Study (2008) (20)
How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction. (2013) (20)
Anger, Hostility, and Hospitalizations in Patients With Heart Failure (2015) (19)
The impact of finally publishing a negative study: new conclusions about endothelin antagonists. (2005) (19)
Drug Layering in Heart Failure: Phenotype-Guided Initiation. (2021) (19)
Extracorporeal Ultra fi ltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research (18)
High Concordance Between Mental Stress–Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients: Hemodynamic and Biomarker Correlates (2015) (18)
Cardiodepressant effects of mexiletine in patients with severe left ventricular dysfunction. (1992) (18)
Association of persistent and transient worsening renal function with mortality risk, readmissions risk, length of stay, and costs in patients hospitalized with acute heart failure (2015) (18)
Effect of Exposure to Evidence‐Based Pharmacotherapy on Outcomes After Acute Myocardial Infarction in Older Adults (2012) (18)
Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure. (1994) (18)
Effects of BG9928, an Adenosine A1 Receptor Antagonist, in Patients With Congestive Heart Failure (2011) (17)
Acute congestive heart failure in the emergency department. (2006) (16)
The use of antiarrhythmic agents in heart failure: implications of CAST. (1989) (16)
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (2020) (16)
Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study (2019) (16)
Psychological stress and short-term hospitalisations or death in patients with heart failure (2016) (15)
Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors. (1993) (15)
Deleterious hemodynamic effects of lidocaine in severe congestive heart failure. (1989) (14)
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). (2003) (14)
Acute electrophysiologic effects of amiodarone in patients with congestive heart failure. (1995) (14)
Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy. (2022) (13)
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy. (2005) (12)
Determinants of the renal response to ACE inhibition in patients with congestive heart failure. (1992) (12)
Prognostic indicators: useful for clinical care? (2009) (12)
Associations of perceived stress and state anger with symptom burden and functional status in patients with heart failure (2019) (12)
Hemodynamic effects of the class III antiarrhythmic drug, d-sotalol, in patients with congestive heart failure. (1996) (11)
First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patient with heart failure: A double-blind, randomized, multicenter study (1994) (11)
Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis. (2004) (11)
Additive Effects of β1 389 Arg/Gly α2c 322–325 Wt/Del Genotype Combinations on Adjudicated Hospitalizations and Death in the Beta-Blocker Evaluation of Survival Trial (BEST) (2008) (10)
Clinical trial design in contemporary device studies in heart failure: is there a gold standard? (2014) (10)
Ambulatory Function in Men with and without HIV Infection: Association with Cardiorespiratory Fitness (2013) (10)
Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart Failure (1988) (10)
One Year Changes in Quality of Life for Heart Failure Patients in a Home Telemonitoring Program (2006) (9)
Management of Sleep Disordered Breathing in Patients with Heart Failure (2018) (9)
Impedance cardiography: More questions than answers (2006) (9)
Selective activation of neurohormonal systems in post-infarction left ventricular dysfunction (1991) (9)
The neurohormonal paradigm: have we gone too far? (2003) (9)
Prognostic importance of the length of ventricular tachycardia in patients with nonischemic congestive heart failure. (1995) (9)
Robust gene expression with amplified RNA from biopsy-sized human heart tissue. (2007) (9)
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS) (2021) (8)
Observation of Patients Transitioned to an Oral Loop Diuretic Before Discharge and Risk of Readmission for Acute Decompensated Heart Failure. (2017) (8)
Treating female heart failure patients with metoprolol CR/XL (2002) (8)
Hemodynamic and neurohormonal effects of quinidine in patients with severe left ventricular dysfunction secondary to coronary artery disease or idiopathic dilated cardiomyopathy. (1991) (8)
A New Clinically Applicable Measure of Functional Status in Patients With Heart Failure: The 60-Foot Walk Test. (2017) (8)
Morbidity and Mortality Benefits of Reliable Instrumental Support (2007) (8)
Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure (2012) (8)
Diuretics: are our ideas based on knowledge? (2011) (7)
Comparative hemodynamic effects of mexiletine and quinidine in patients with severe left ventricular dysfunction. (1991) (7)
Torsades de Pointes with Administration of High‐Dose Intravenous d‐Sotalol to a Patient with Congestive Heart Failure (1997) (7)
Coordinated Care, Telemonitoring, and the Therapeutic Relationship: Heart Failure Management in the United States (2006) (7)
1169Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy (2019) (7)
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction. (2021) (6)
Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects. (1995) (6)
Impact of Mental Stress and Anger on Indices of Diastolic Function in Patients with Heart Failure. (2020) (6)
First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators. (1994) (6)
Depression and HIV Infection are Risk Factors for Incident Heart Failure Among Veterans: Veterans Aging Cohort Study. (2015) (6)
The Effect of Coenzyme Q 10 in Patients with Congestive Heart Failure (2015) (5)
The impact of beta-blockade on mortality rates in patients with congestive heart failure. (2000) (5)
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis (5)
Heart Failure Spending Function: An Investment Framework for Sequencing and Intensification of Guideline-Directed Medical Therapies (2022) (5)
Beta-blockers after myocardial infarction. (1979) (4)
The use of pacemakers as treatment for systolic dysfunction. (1998) (4)
Abnormal Valsalva blood pressure response in dilated cardiomyopathy: association with "pseudonormalization" of echocardiographic Doppler transmitral filling velocity pattern. (1993) (4)
Should we overcome the resistance to bioelectrical impedance in heart failure? (2020) (4)
Contemporary Reviews in Cardiovascular Medicine Cardiorenal Syndrome New Perspectives (2010) (4)
Are all β-blockers the same for chronic heart failure? (2001) (4)
Use of Outpatient Intravenous Calcitropes for Heart Failure in the United States. (2021) (4)
Beta-blockers for heart failure: where are we now? (1994) (3)
Metoprolol Reverses Left Ventricular Remodeling in Patients with Asymptomatic Systolic Dysfunction: The REVERT Trial (2005) (3)
TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study. (2022) (3)
Are all beta-blockers the same for chronic heart failure? (2001) (3)
Rapamycin-based and late FK506-light immunosuppression in heart transplant recipients (2003) (3)
Warfarin usage among elderly atrial fibrillation patients with traumatic injury, an analysis of United States Medicare fee‐for‐service enrollees (2015) (3)
Use of patient‐reported outcomes in heart failure: from clinical trials to routine practice (2023) (3)
Carpal Tunnel Syndrome and Future Amyloidosis: Time to Heed the Warning Sign. (2019) (3)
University of Groningen Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure Current Status and Prospects for Further Research (2017) (3)
Association of Worsening Renal Function with Length of Stay and Costs in Patients Hospitalized with Acute Heart Failure (2014) (3)
Chapter 44 – Management of Volume Overload in Heart Failure (2011) (3)
Cardiac Calcitropes, Myotropes, andMitotropes (3)
Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation. (2022) (3)
Walking the line of euvolemia. (2014) (2)
Theory and Fact: Revisiting Association and Causation. (2017) (2)
Relation of Depression to Severity of Illness in Heart Failure (From HF-ACTION [Heart Failure and a Controlled Trial Investigating Outcomes of Exercise)] Training) (2009) (2)
Highlights of the 2006 scientific sessions of the Heart Failure Society of America: Seattle, Washington, September 10-13, 2006. (2007) (2)
Implantable cardioverter-defibrillator therapy after myocardial infarction. (2005) (2)
Exercise improves exercise duration more than peak VO2 in elderly patients with congestive heart failure (1998) (2)
Severe Chronic Heart Failure (2005) (2)
New approaches to managing congestive heart failure. (1995) (2)
Oral levosimendan, a novel myofilament calcium sensitizer, is an effective substitute for intravenous inotropic therapy in class IV inotrope-dependent heart failure patients (1999) (2)
Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial (2018) (2)
Insomnia symptoms and biomarkers of monocyte activation, systemic inflammation, and coagulation in HIV: Veterans Aging Cohort Study. (2021) (2)
Beta-blockers post-MI: an example of age discrimination? (2002) (1)
A rapid BNP assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter study (2002) (1)
Effects of Single IV Doses of BG9928, an Adenosine A1 Antagonist, in Patients with Heart Failure (2008) (1)
Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction (2004) (1)
Enhanced external counterpulsation: what can we learn from the treatment of neurasthenia? (2006) (1)
Perioperative heart failure in noncardiac surgery (2010) (1)
Trajectories of Renal Function During Heart Failure Hospitalization: Beware the Bumpy Ride! (2019) (1)
PREDICTORS OF URINE OUTPUT AND THE EFFECTS OF NESIRITIDE IN ACUTE DECOMPENSATED HEART FAILURE: RESULTS FROM ASCEND-HF (2013) (1)
Abstract 901: Effects of Bucindolol on Cardiovascular Mortality and Morbidity are Determined by the Beta-1 389 Arg/Gly Receptor Polymorphism (2007) (1)
Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated Cardiomyopathy. (2022) (1)
Long-term efficacy of coenzyme Q10 therapy for congestive heart failure (1999) (1)
Abstract 18446: Receipt of Implantable Cardioverter-Defibrillator Among HIV+ and HIV- Veterans With Cardiomyopathy (2013) (1)
Treatment of Arrhythmia in Patients with Heart Failure (1990) (1)
Treatment of Congestive Heart Failure (2013) (1)
Increased Resting Metabolic Rate in Congestive Heart Failure (1995) (1)
Prognostic Value of the Signal-Averaged Electrocardio lschemic an % ram and a prolonged QRS in Nonischemic Cardiomyopathy (1995) (1)
The hemodynamic actions of the antiarrhythmic agent ipazilide fumarate in patients with congestive heart failure (1994) (1)
Acute decompensated heart failure. (2012) (1)
Levosimendan rapidly lowers plasma endothelin-1 and TNF-alpha levels in patients with severe heart failure (1999) (1)
Arrhythmias and sudden death in congestive heart failure (1989) (1)
Can acute hemodynamic studies in heart failure be used to predict the optimal dose of a new drug during long-term therapy? (1991) (1)
Exercise in the geriatric patient with congestive heart failure. (2001) (1)
The Incidence of Right Ventricular Dysfunction Is Similar in Pulsatile and Continuous-Flow Left Ventricular Assist Devices (2006) (0)
Abstract P230: Antidepressant Use and Incident Heart Failure among Veterans with and without HIV Infection and Major Depressive Disorder (2015) (0)
Effects of Acute and Chronic Stress on Heart Failure Functional Status, Hospitalization and Mortality (2014) (0)
A four-part regimen for clinical heart failure. (1999) (0)
SLEEP APNEA AND FREE FATTY ACIDS IN SUBJECTS WITH HEART FAILURE effects of Sleep Apnea on Nocturnal Free Fatty Acids in Subjects with Heart Failure is common in patients with (2011) (0)
The Association of Sodium Intake and Objective and Subjective Indicators of Heart Failure Severity (2011) (0)
Pharmacokinetics, neurohormone levels, and safety evaluation of single doses of valsartan in patients with congestive heart failure (1999) (0)
Factors Associated with Chronic Worsening of Renal Function in Stable Heart Failure Patients in an Ambulatory Setting (2012) (0)
Abstract 2912: Effect of {beta}1 389 Arg/Gly {alpha}2c 322 325 Wt/Del Genotypes on Adjudicated Hospitalizations in the BEST Trial (2007) (0)
Abstract 16594: Elevated Levels of Galectin-3 are Associated with Higher Levels of C-Reactive Protein, Increased Disease Severity and Poorer Prognosis in Patients with Chronic Heart Failure (2012) (0)
Specific Causes of 30-Day and 1-Year Readmissions in Heart Failure Patients (2019) (0)
Validation of an Effective and Easily-Administered Walk Test Measure of Functional Status in Heart Failure Patients: Comparison of the 60 Foot and 6 Minute Walk Tests (2010) (0)
The Characteristics of Out-Patient Use of Intravenous Milrinone in the United States (2019) (0)
Acute Congestive Heart Failure in the Emergency (2006) (0)
The effects of methylcholanthrene on the demethylation of dimethylnitrosamines in two mouse strains. (1974) (0)
Effects of Nutritional Status on the Reported Long-term Decrease in eGFR after LVAD Implantation (2018) (0)
Comprar Depression and Heart Failure, An Issue of Heart Failure Clinics | Philip Binkley | 9781455704576 | Saunders (2011) (0)
A Randomized, Controlled Trail of the Renal Effects of Ultrafiltration as Compared to Furosemide (2007) (0)
HowMedicare Part D Benefit Phases Affect Adherence with Evidence-Based Medications Following Acute Myocardial Infarction (2013) (0)
Fatigue in Heart Failure (2022) (0)
Whither digitalis? What we can still learn from cardiotonic steroids about heart failure and hypertension. (2022) (0)
Abstract 284: Association of Worsening Renal Function With Mortality and Heart Failure Readmissions in Patients Hospitalized With Acute Heart Failure (2015) (0)
Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial (2023) (0)
Heart failure at the beginning of the 21st century (2001) (0)
Chronic Heart Rate of 90 Leads to Clinical Deterioration and Lower Ejection Fraction in Patients with Heart Failure (2006) (0)
Surrogate Endpoints: Not the Real Thing. (2016) (0)
Low prevalence of hypomagnesemia in CHF as a result of ACE inhibition (1991) (0)
Preface: depression and heart failure. (2011) (0)
UNLOAD Response to Letter to the Editor (2008) (0)
Transcription Profiles of Failing and Non-Failing Hearts after Two-Cycle RNA Amplification from Biopsy-Sized Samples (2006) (0)
The Use of Radiation Therapy Does Not Appear to Have an Impact on the Incidence of Heart Failure in Patients Receiving Targeted HER2 Based Systemic Therapy (2015) (0)
SEVERE PHYSICAL INACTIVITY PERSISTS FOLLOWING ACUTE HEART FAILURE IN PATIENTS WITH SLEEP DISORDERED BREATHING (2017) (0)
Dispelling the Myths: Treatment of Patients with Ischemic Heart Disease and Left Ventricular Dysfunction (1996) (0)
Do different beta-blockers cause different mortality effects following a myocardial infarction? (2000) (0)
Title Depression and HIV Infection are Risk Factors for Incident Heart Failure Among Veterans : Veterans Aging Cohort Study Permalink (0)
Diuretic Strategies and Renal Dysfunction in Heart Failure With Preserved Ejection Fraction. (2018) (0)
DURATION OF ORAL LOOP DIURETICS AND 30-DAY READMISSION IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE (2017) (0)
PREVALENCE, PREDICTORS AND EFFECTS OF NESIRITIDE ON CHANGES IN RENAL FUNCTION DURING HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE : RESULTS FROM ASCEND-HF (2013) (0)
Using and misusing statistics: what do we know about the effects of race on the impact of β-blockers? (2012) (0)
he Adequacy of Laboratory onitoring in Patients Treated With pironolactone for Congestive Heart Failure (2016) (0)
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary. (2023) (0)
PREVALENCE, PREDICTORS AND EFFECTS OF NESIRITIDE ON CHANGES IN RENAL FUNCTION DURING HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE (2013) (0)
Book Review Heart Failure: A Combined Medical and Surgical Approach Edited by Patrick M. McCarthy and James B. Young. 314 pp., illustrated. Malden, MA, Blackwell Futura, 2007. $99.95. 978-1-4051-2203-0 (2007) (0)
Segment Length and Risk for Neoplastic Progression in Patients with Barrett Esophagus (2000) (0)
Depressive Symptoms in Heart Failure: What is the Relationship with Inflammation and Fibrosis? (2012) (0)
Is aerobic exercise training safe and beneficial in elderly CHF patients (1994) (0)
Changes in Depression, Anxiety, and Social Support in Heart Failure Outpatients with Implantable Cardioverter Defibrillators (2006) (0)
Congruity between Mental Stress-Induced and Adenosine-Induced Myocardial Ischemia Assessed Using SPECT in Heart Failure Patients (2014) (0)
Long-term Effects of Perceived Stress, Anxiety, and Anger on Hospitalizations or Death and Health Status in Heart Failure Patients (2021) (0)
The Frequency and Prognosis of Cardiotoxicity from Trastuzumab (2012) (0)
Amiodarone after myocardial infarction: EMIAT and CAMIAT trials (1997) (0)
Effects of Lixivaptan, a Novel Vasopressin V2 Receptor Antagonist, in Chronic Heart Failure: Results from a Double-Blind, Placebo-Controlled, Multiple-Dose Study (2008) (0)
Can We Expect Vasodilator Therapy to Prolong Life in Patients with Congestive Heart Failure? (1987) (0)
1031-37 Does ACE Inhibition Affect the Response to IV Digoxin? (1995) (0)
Abstract 10576: Long-Acting Fc-elabela Improves Heart Functional Performance and Markedly Reduces the Infarction Area in a Non-Human Primate Model of Myocardial Infarction (2021) (0)
Depression and Heart Failure, An Issue of Heart Failure Clinics (2011) (0)
965-47 Comparison of Regional Myocardial Blood Flow and Metabolism in Patients with Ischemic and Non-ischemic Cardiomyopathy (1995) (0)
Beta blockade improves survival in patients with congestive heart failure (1999) (0)
What Do the Newer Trials Tell Us About the Management of Heart Failure? A Discussion of Three Thought-Provoking Papers (2020) (0)
Supported by a grant from Boehringer Mannheim Corporation, Gaithersburg, Maryland.The Effects of Diuresis on the Pharmacokinetics of the Loop Diuretics Furosemide and Torsemide in Patients with Heart Failure - clinical and neuroendocrine effect of introducing diuretics (1998) (0)
THE EFFECT OF CARDIAC TRANSTHYRETIN AMYLOIDOSIS ON RENAL DISEASE PROGRESSION (2016) (0)
ffect of Kidney Transplantation on eft Ventricular Systolic Dysfunction nd Congestive Heart Failure in atients With End-Stage Renal Disease (2016) (0)
Effect of Beta Blockade on Mortality in Patients With Contraindications Post Myocardial Infarction (1998) (0)
Quality of life and depression in congestive heart failure: Do race and gender matter? (2003) (0)
patients with congestive heart failure Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in (2011) (0)
Observation of Patients Transitioned to an Oral Loop Diuretic Prior to Discharge and Risk of Readmission for Acute Decompensated Heart Failure Short Title: Oral Loop Diuretics and Risk of Readmission for Acute Decompensated Heart Failure (2017) (0)
Hypoxia, Not the Frequency of Sleep Apnea, Causes Acute Hemodynamic Stress in Patients with Congestive Heart Failure (2009) (0)
Randomized crossover comparison of the hemodynamic of three type I antiarrhythmic in heart failure (1990) (0)
Acute Electrophrsiolo@c Effects of Amiodarone m Patients With Congestive Heart Failure (1995) (0)
Depression, cardiovascular symptom reporting, and functional status in heart failure patients (abstract) (2011) (0)
Baseline Cystatin C is Associated with Short-Term Adverse Events in Acute Heart Failure but Does Not Predict Treatment Effects with Nesiritide Therapy (2011) (0)
Time to practice what we preach: the use of beta-blockers post myocardial infarcation. (1999) (0)
Aging issues: cardiopulmonary and renal impairments: crosscutting breakout session. Physical Disabilities through the Lifespan Conference. (2005) (0)
One Year Changes in Survival, Physiologic Measures and Quality of Life for Heart Failure Patients in a Home Telemonitoring Program (2011) (0)
1088-126 Nesitride does not improve renal function in patients with chronic heart failure and worsening creatinine (2004) (0)
Epidemiology and Outcomes in Combined Cardiorenal Disease : The Scope of the Problem Prevalence of Renal Disease in Patients With HF (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephen S. Gottlieb?

Stephen S. Gottlieb is affiliated with the following schools: